News
-
Toyobo will exhibit cutting-edge technologies at IDTechEx Show!: Highlights include XENOMAX®, COCOMI™ and Zylon® products that help make daily lives richer and more convenient
-
Presentation to Investors (1.4MB)
-
Consolidated Financial Report for the First Half ended September 30, 2019 (339KB)
-
Toyobo and Saline Water Conversion Corporation sign MOU on joint pilot test aimed at accelerating use of new membrane technology for reusing concentrated brine
-
Notice regarding the completion of stock acquisitions and changes in the trade names of subsidiaries (152KB)
-
Toyobo to market RNA Analysis Kit based on RIKEN technology to help develop genomic medicine
-
Toyobo joins European consortium CEFLEX to help develop a circular economy for flexible packaging
-
Presentation to Investors (690KB)
-
Consolidated Financial Report for the First Quarter ended June 30, 2019 (293KB)
-
Accelerating development of material for organic photovoltaics capable of generating power with indoor light
-
Toyobo obtains government approval to produce and sell bone regeneration inducing material Bonarc™
-
Notice of the 161st Annual General Meeting of Shareholders
-
Notice of stock acquisitions making two firms subsidiaries (129KB)
-
Presentation to Investors (757KB)
-
Consolidated Financial Report for Year ended March 31, 2019 (345KB)
-
The promotional video of TOYOBO's concept car is now available
-
Toyobo signs contract with Plug and Play to develop new business through open innovation
-
Toyobo joins European venture fund to accelerate growth in “sustainable chemistry” field
-
Presentation to Investors (627KB)
-
Consolidated Financial Report for the Third Quarter ended December 31, 2018 (234KB)
-
Toyobo signs sales contract with TERPHANE to market ECOSYAR® in Americas
-
Toyobo develops TOYOBO ESTER® GS, an eco-friendly packaging film
-
Presentation to Investors (1.4MB)
-
Consolidated Financial Report for the First Half ended September 30, 2019 (339KB)
-
Notice regarding the completion of stock acquisitions and changes in the trade names of subsidiaries (152KB)
-
Presentation to Investors (690KB)
-
Consolidated Financial Report for the First Quarter ended June 30, 2019 (293KB)
-
Notice of the 161st Annual General Meeting of Shareholders
-
Notice of stock acquisitions making two firms subsidiaries (129KB)
-
Presentation to Investors (757KB)
-
Consolidated Financial Report for Year ended March 31, 2019 (345KB)
-
Presentation to Investors (627KB)
-
Consolidated Financial Report for the Third Quarter ended December 31, 2018 (234KB)
-
Toyobo will exhibit cutting-edge technologies at IDTechEx Show!: Highlights include XENOMAX®, COCOMI™ and Zylon® products that help make daily lives richer and more convenient
-
Toyobo and Saline Water Conversion Corporation sign MOU on joint pilot test aimed at accelerating use of new membrane technology for reusing concentrated brine
-
Toyobo to market RNA Analysis Kit based on RIKEN technology to help develop genomic medicine
-
Accelerating development of material for organic photovoltaics capable of generating power with indoor light
-
Toyobo obtains government approval to produce and sell bone regeneration inducing material Bonarc™
-
The promotional video of TOYOBO's concept car is now available
-
Toyobo signs sales contract with TERPHANE to market ECOSYAR® in Americas
-
Toyobo develops TOYOBO ESTER® GS, an eco-friendly packaging film
-
Toyobo Co., Ltd. distributes news releases via RSS. By subscribing to a special software called an RSS reader or a browser that supports RSS, you can get information automatically when news is updated without visiting the site.
Cautionary Statement
This website contains forward-looking statements that reflect Toyobo's plans and expectations. These forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause Toyobo's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.